Blog

Welcome to CrownBio’s Blog where we share our thoughts
on the latest trends and hot stories in Oncology and CVMD

blog.png
iStock_000049858330_Medium-cropped-resized.png

A team led by Professor Griffiths at the University of Cambridge has captured in a stunning video the behaviour of cytotoxic T cells encountering cancer cells through high-resolution 3D time-lapse multi-colour imaging, obtained using avant-garde microscopy techniques.

Read more
Magnifying-glass_resized-638x300.png

The diabetes market was estimated in excess of $35.6 billions in 2014 and is still dominated by various forms of injectable insulin that alone represent a 55% share of the total market. The biopharmaceutical industry has recognized the need for better, alternative treatments and, as we advance our understanding of the root causes of the disease, has developed the next generation of anti-diabetes drugs.

Read more
beast_Medium-resized.png

Immunotherapy is beyond a shadow of a doubt the most popular topic among cancer experts. Specialist press coverage on the most recent clinical trial results has been accompanied by an unprecedented social media buzz that has contributed to the maturation of a collective view of immunotherapy as the treatment set to revolutionize cancer therapy.

Read more
iStock_000004801211_Medium-Resized.png

Pancreatic cancer is the fourth most common cause of cancer death worldwide with nearly 300,000 deaths per year. Around 50,000 new cases are diagnoses yearly in the US alone. Patients’ life expectancy is dramatically low with only 20% of early spotted cases surviving for five years after initial diagnosis and these numbers drop drastically for cases diagnosed at more advanced stages. A new drug application has been recently submitted for MM-398 in combination with standard therapy for patients with metastatic pancreatic cancer potentially brightening their clinical prospects.

Read more